Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    "Microscopic polyangiitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Microscopic polyangiitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Wegener's
Intervention:
2 Unknown  CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
Conditions: Polyarteritis Nodosa;   Microscopic Polyangiitis
Interventions: Drug: azathioprine;   Drug: cyclophosphamide
3 Active, not recruiting An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic Polyangiitis
Intervention:
4 Recruiting A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic Polyangiitis
Intervention: Drug: rituximab [MabThera/Rituxan]
5 Completed
Has Results
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Conditions: Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis
Interventions: Drug: Rituximab plus cyclophosphamide placebo (rituximab group);   Drug: Cyclophosphamide plus rituximab placebo (control group);   Drug: Azathioprine;   Drug: Methylprednisolone (or other glucocorticoid);   Drug: Prednisone
6 Completed CellCept in p-ANCA Vasculitis
Conditions: MPO-ANCA Vasculitis;   Microscopic Polyangiitis
Intervention: Drug: CellCept (mycophenolate mofetil)
7 Recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine
8 Active, not recruiting Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Renal Limited Forms
Interventions: Drug: Rituximab (Arm B);   Drug: Rituximab (Arm A)
9 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:
10 Not yet recruiting Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
Conditions: ANCA-associated Vasculitis;   Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   EosinphilicGranulomatosis With Polyangiitis
Intervention:
11 Not yet recruiting BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Interventions: Drug: Blisibimod;   Drug: Placebo
12 Unknown  PRO Development for ANCA Associated Vasculitis
Conditions: Wegener Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome
Intervention:
13 Completed Efficacy Study of Two Treatments in the Remission of Vasculitis
Conditions: Wegener's Granulomatosis,;   Microscopic Polyangiitis
Interventions: Drug: Rituximab;   Drug: Azathioprine
14 Completed RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Conditions: Wegener's Granulomatosis;   Churg-Strauss Syndrome;   Microscopic Polyangiitis
Interventions: Drug: Infliximab;   Drug: Rituximab
15 Recruiting Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA)
Interventions: Procedure: Plasma Exchange;   Drug: Glucocorticoids
16 Active, not recruiting Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis NODOSA or Churg Strauss Syndrome
Conditions: MPA;   FFS=0;   At Diagnosis or Within the First 15 Days Following;   Initiation of Corticosteroids.
Interventions: Drug: corticosteroid and azathioprine;   Drug: corticosteroid and placebo
17 Recruiting Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Interventions: Drug: Glucocorticoids;   Drug: Rituximab
18 Enrolling by invitation Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Intervention: Other: Observational
19 Completed Vasculitis Illness Perception (VIP) Study
Conditions: Wegener Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu's Arteritis;   Henoch-Schoenlein Purpura;   Behcet's Disease;   CNS Vasculitis
Intervention:
20 Recruiting Low-dose Glucocorticoid Vasculitis Induction Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Drug: Rituximab;   Drug: Glucocorticoids

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years